Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

aTyr Pharma Inc. (LIFE)

12.79   1.27 (11.02%) 09-23 14:50
Open: 11.71 Pre. Close: 11.52
High: 12.89 Low: 11.6
Volume: 5,626,624 Market Cap: 336M
aTyr Pharma, Inc. develops protein therapeutics and novel class of biologic drugs. The company is headquartered in San Diego, California and currently employs 42 full-time employees. The firm is engaged in the discovery and clinical development of medicines for patients suffering from severe, rare diseases using its Physiocrine biology, a discovered set of physiological modulators. The firm focuses on the development of Physiocrine-based therapeutics for the treatment of rare diseases, including facioscapulohumeral muscular dystrophy (FSHD) and limb-girdle muscular dystrophy (LGMD) 2B. The firm is developing Resolaris, an intravenous protein therapeutic for the treatment of rare myopathies with an immune component (RMICs). The firm is investigating Resolaris in patients with LGMD2B. The firm is conducting approximately three open label trials in patients with early onset FSHD, in adult patients with FSHD or LGMD2B and a long-term extension study in adult patients with FSHD. The firm has not generated any revenues.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 12.349 - 12.408 12.408 - 12.463
Low: 10.221 - 10.279 10.279 - 10.333
Close: 11.902 - 12.005 12.005 - 12.103

Technical analysis

as of: 2021-09-23 2:42:36 PM
Overall:       
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 15.15     One year: 17.69
Support: Support1: 7.74    Support2: 4.50
Resistance: Resistance1: 12.97    Resistance2: 15.15
Pivot: 7.95
Moving Average: MA(5): 10.86     MA(20): 7.30
MA(100): 5.05     MA(250): 4.50
MACD: MACD(12,26): 1.64     Signal(9): 1.10
Stochastic oscillator: %K(14,3): 78.01     %D(3): 72.08
RSI: RSI(14): 81.70
52-week: High: 12.97  Low: 2.93  Change(%): 199.2
Average Vol(K): 3-Month: 1030056  10-Days: 3047754

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
LIFE has closed below upper band by 13.9%. Bollinger Bands are 684% wider than normal. The large width of the bands suggest high volatility as compared to LIFE's normal range. The bands have been in this wide range for 7 bars. This is a sign that the current trend might continue.

Headline News

Thu, 23 Sep 2021
Is aTyr Pharma Inc (LIFE) Stock Worth a Buy Thursday? - InvestorsObserver

Thu, 23 Sep 2021
Thursday 9/23 Insider Buying Report: LIFE, CRDF - Nasdaq

Wed, 22 Sep 2021
Atyr Pharma (LIFE) falls 4.08% on Moderate Volume September 22 - Equities.com

Wed, 22 Sep 2021
Premarket Mover: aTyr Pharma Inc (LIFE) Down 2.25% - InvestorsObserver

Tue, 21 Sep 2021
aTyr Pharma Inc (LIFE) has gained 3.42% Tuesday In Premarket Trading - InvestorsObserver

Mon, 20 Sep 2021
aTyr Pharma Announces Closing of $86.3 Million Public Offering Including Full Exercise of Underwriters' Option to - GlobeNewswire

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 16
Shares Float (M) 14
% Held by Insiders 3.75
% Held by Institutions 49.20
Shares Short (K) 547
Shares Short P. Month (K) 620

Stock Financials

EPS -2.290
EPS Est This Year -2.180
EPS Est Next Year -1.820
Book Value (p.s.) 3.100
Profit Margin
Operating Margin -1322.08
Return on Assets (ttm) -37.7
Return on Equity (ttm) -75.8
Qtrly Rev. Growth
Gross Profit (p.s.) -0.426
Sales Per Share 0.137
EBITDA (p.s.) -1.781
Qtrly Earnings Growth
Operating Cash Flow (M) -24
Levered Free Cash Flow (M) -13

Stock Valuations

PE Ratio -5.03
PEG Ratio
Price to Book value 3.72
Price to Sales 84.10
Price to Cash Flow -7.56

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date 2019-06-30
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.